No Data
No Data
Moderna's skin cancer vaccine mRNA-4157 is expected to enter the market as early as 2025.
According to reports, moderna is planning to launch a mRNA-based skin cancer vaccine, mRNA-4157, as early as next year. The vaccine will be used in combination with merck's PD-1 therapy Keytruda for the treatment of melanoma.
Merck & Co To Go Ex-Dividend On September 16th, 2024 With 0.77 USD Dividend Per Share
US stocks closed: Technology breaks through to lift the index, Nasdaq and S&P jointly achieve four consecutive gains.
① After four consecutive days of gains, the S&P 500 index is still 1.3% away from its historical high. ② Warren Buffett's deputy sold more than half of Berkshire Hathaway's positions, causing the stock price to fall for the seventh consecutive day. ③ AirPods Pro transforms into an OTC hearing aid, with FDA approval for Apple's hearing assistance software. ④ Gilead's HIV prevention drug delivers positive results once again.
Moderna Cites 2025 Launch for Merck Partnered Cancer Vaccine: Report
Moderna Cost Cuts Fail to Restore Investor Trust -- WSJ
Equitable Breakthroughs in Medicine Development (EQBMED) to Work With Inaugural Sponsor Companies to Drive Greater Diversity in Clinical Trials
No Data
No Data
Bunny R :
SeanDiamond13 : If Harris wins im selling everything & investing in Gold
Tonyco :
Joe P :
tough Platypus_9271 : Harris will say anything to get elected . She has no experience in anything but a prosecutor for California and you see how that went. The emergent.czar , you see how that went too. If she is president, she will not be in charge, she knows nothing about the job, and you really want her to sit down with Putin? This is the worst time to even consider her. Watch the debate tonight at 9 eastern time.
View more comments...